Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
BridgeBio Pharma Inc banner

BridgeBio Pharma Inc
XBER:2CL

Watchlist Manager
BridgeBio Pharma Inc Logo
BridgeBio Pharma Inc
XBER:2CL
Watchlist
Price: 0.057 EUR Market Closed
Market Cap: €8.4m
Write Note Create Alert Ask AI

Intrinsic Value

2CL price has not been updated for more than 7 years. This may indicate that the stock has been delisted.

The intrinsic value for BridgeBio Pharma Inc (2CL) under the Base Case is 0.033 EUR. Compared with the current market price of 0.057 EUR, the stock appears Overvalued by 42% .

Based on two methods:
DCF Value
€0.024
Multiples-Based Value
€0.042
DCF Value
€0.024
Multiples-Based Value
€0.042

Both DCF and multiples point to overvaluation.

2CL Intrinsic Value
0.033 EUR
Overvaluation 42%
Intrinsic Value
Price €0.057
Bear Case
Base Case
Bull Case
Monitor 2CL
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €0.03
Get notified when the price drops into your buy zone
Current Price €0.06
Intrinsic Value €0.03
Margin of Safety 20% €0.03
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
What is Valuation History?
Ask AI Assistant
What other research platforms think about 2CL?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is 2CL valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for BridgeBio Pharma Inc.

Explain Valuation
Alternatives to 2CL

Fundamental Analysis

Financials
Efficiency

Earnings Waterfall
BridgeBio Pharma Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

BBIO Insider Trading
Buy and sell transactions by insiders

See Also

Summary
2CL intrinsic value, competitors valuation, and company profile.
DCF Valuation
2CL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
2CL stock valuation using valuation multiples.
Wall St Estimates
2CL price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
2CL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other BridgeBio Pharma Inc listings:
NASDAQ • USD
BBIO
Discover More
What is the Intrinsic Value of one 2CL stock?

The intrinsic value for BridgeBio Pharma Inc (2CL) under the Base Case is 0.033 EUR.

Is 2CL stock undervalued or overvalued?

Compared with the current market price of 0.057 EUR, the stock appears Overvalued by 42% .

Back to Top
ALPHA SPREAD
Follow us
Join 341,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett